Alzheimer's Hero Image

A brain disease that impairs memory, thinking and behavior. It’s the most common form of dementia, characterized by progressive and chronic deterioration of cognitive functions, including memory, thinking and reasoning.


LATEST ARTICLES


RELATED ARTICLES

Tackling Neurological Disorders in New Ways

Chronic pain. Alzheimer's disease. Multiple Sclerosis. Brain tumors. These are some of the most well-known and prevalent diseases afflicting the more than 100 million Americans who are impacted by a neurological disorder.

Disrupting Alzheimer's Disease thumbnail

Disrupting Alzheimer's Disease

Researchers, patient advocates and policymakers recently gathered in Chicago to discuss the unique challenges that make up Alzheimer's research and what the future holds for the 5.7 million Americans living with the disease.

Tackling Neurological Disorders in New Ways image

Tackling Neurological Disorders in New Ways

Chronic pain. Alzheimer's disease. Multiple Sclerosis. Brain tumors. These are some of the most well-known and prevalent diseases afflicting the more than 100 million Americans who are impacted by a neurological disorder.

Researcher Profile: Eva Kohegyi image

Researcher Profile: Eva Kohegyi

Dr. Eva Kohegyi specializes in research for medications in neurologic and psychiatric indications, including the development of treatments for patients with Alzheimer's disease, Tourette's disease, schizophrenia, bipolar disorder and other illnesses of the central nervous system.

Researcher Profile: Ian Reynolds image

Researcher Profile: Ian Reynolds

Ian leads the Small Molecule Discovery Group at Teva Pharmaceuticals, where he is focused on drug discovery for neurological and neurogenerative diseases, such as Parkinson’s and multiple sclerosis (MS).

Researcher Profile: Matthew Kennedy image

Researcher Profile: Matthew Kennedy

Matt has spent the majority of his nearly 20-year career in drug discovery searching for a cure to one of the most challenging diseases, Alzheimer's.

Researcher Profile: Darryle Schoepp image

Researcher Profile: Darryle Schoepp

Darryle Schoepp has been involved in drug research for over 30 years, and wears many hats at Merck.

Explore Genomics in Virtual Reality image

Explore Genomics in Virtual Reality

Every day, within laboratories across the country, biopharmaceutical researchers are pioneering the latest advancements in science and discovery, and working to transform the future of medicine.

Researcher Profile: Dan Skovronsky image

Researcher Profile: Dan Skovronsky

A neuroscientist and neuropathologist by training, Dan is responsible for development across all of Lilly's products - from clinical trials through approvals - specifically working within the areas of oncology, diabetes, Alzheimer's disease, immunology and pain management.

On the Front Lines of Science image

On the Front Lines of Science

In recent years, medical breakthroughs including new drug therapies and early disease monitoring technologies have accelerated rapidly. This has created wide-ranging transformations in patient care.

Brain Awareness Week image

Brain Awareness Week

For all we have accomplished in neuroscience, our understanding of human brain function and the diseases that affect it remains a tremendous challenge for researchers.

Using Setbacks as Stepping Stones in Alzheimer's Research image

Using Setbacks as Stepping Stones in Alzheimer's Research

Biopharmaceutical researchers are exploring promising, new approaches to treating and preventing Alzheimer's disease.